Debt-to-equity of Phio Pharmaceuticals Corp. from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Phio Pharmaceuticals Corp. quarterly Debt-to-equity in % history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • Phio Pharmaceuticals Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 14%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Phio Pharmaceuticals Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 14% 30 Sep 2025
Q4 2023 27% +11% +64% 31 Dec 2023
Q3 2023 26% +10% +63% 30 Sep 2023
Q2 2023 22% +7.6% +54% 30 Jun 2023
Q1 2023 20% +8.1% +67% 31 Mar 2023
Q4 2022 17% +6.2% +59% 31 Dec 2022
Q3 2022 16% +4.9% +46% 30 Sep 2022
Q2 2022 14% +2% +16% 30 Jun 2022
Q1 2022 12% -1.4% -11% 31 Mar 2022
Q4 2021 10% -7.3% -41% 31 Dec 2021
Q3 2021 11% -8.5% -44% 30 Sep 2021
Q2 2021 12% -10% -45% 30 Jun 2021
Q1 2021 13% -14% -50% 31 Mar 2021
Q4 2020 18% -8.7% -33% 31 Dec 2020
Q3 2020 19% -0.9% -4.4% 30 Sep 2020
Q2 2020 22% 30 Jun 2020
Q1 2020 27% 31 Mar 2020
Q4 2019 26% 31 Dec 2019
Q3 2019 20% 30 Sep 2019
Q4 2013 26% +77% 31 Dec 2013
Q3 2013 41% +127% 30 Sep 2013
Q2 2013 140% 30 Jun 2013
Q1 2013 -135% 31 Mar 2013
Q4 2012 -52% 31 Dec 2012
Q3 2012 -87% 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.